RLAY- Relay Therapeutics, Inc.

Name: Relay Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Relay Therapeutics, Inc. (RLAY) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. RLAY is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Patel Sanjiv	1.45M	$18.80M	-
Dir	Mazumdar Claire	421.2K	$5.46M	-
Pres	Bergstrom Donald A	420.0K	$5.45M	-
Other	Adams Brian	371.5K	$4.82M	-
Other	Rahmer Peter	276.6K	$3.59M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 29, 2025	Rahmer Peter63	See Remarks	Sell	17,083	$3.68	$62,946.98	-2.2%	+103.9%	-
Jul 29, 2025	Catinazzo Thomas71	Chief Financial Officer	Sell	20,081	$3.69	$74,000.14	-2.8%	+103.9%	-
Jul 29, 2025	Bergstrom Donald A75	President, R&D	Sell	30,770	$3.69	$113,477.74	-2.6%	+103.9%	-
Jul 29, 2025	Adams Brian72	Chief Legal Officer	Sell	19,913	$3.68	$73,378.06	-2.5%	+103.9%	-
Jul 9, 2025	Patel Sanjiv74	President And CEO	Sell	61,379	$3.57	$219,123.03	-3.8%	+53.0%	-
Apr 30, 2025	Rahmer Peter63	See Remarks	Sell	12,103	$3.02	$36,540.88	-1.5%	+8.7%	+289.2%
Apr 30, 2025	Catinazzo Thomas71	Chief Financial Officer	Sell	19,191	$3.07	$58,848.64	-1.3%	+8.7%	+289.2%
Apr 30, 2025	Bergstrom Donald A75	President, R&D	Sell	31,562	$3.02	$95,381.30	-2.6%	+8.7%	+289.2%
Apr 30, 2025	Adams Brian72	Chief Legal Officer	Sell	14,587	$3.02	$44,040.48	-1.8%	+8.7%	+289.2%
Apr 23, 2025	Patel Sanjiv74	President And CEO	Sell	61,422	$2.97	$182,423.34	-3.6%	+19.3%	+385.2%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC